BioSpace News Archive

Biosenta Inc. (“ Biosenta ” or the “ Company ”) listed on the CSE (CSE: ZRO) is pleased to announce the finalization of a four-year research partnership with the University of Calgary. Biosenta has wasted no time in creating innovation in Alberta. A research partnership with the University of Calgary Research Group and AMPAK Inc. from Toronto, Ontario, is official. This partnership enables the University team to undertake a new generation of resea

Clinical research organization Celerion today announced its successful reaccreditation by the Association for the Accreditation of Human Research Protection Programs (AAHRPP).

Cyxone AB (publ), a Swedish biotech company dedicated to developing improved treatments for autoimmune diseases, announces today that it has initiated a process to optimize the development plan for Rabeximod.

A broad array of consumer, medical, parents, and environmental groups are lauding a new safety communication from the U.S. Food and Drug Administration that recommends against use of dental amalgam in children and many women.

Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced the pricing of its initial public offering of 8,325,000 shares of its common stock at a public offering price of $19.00 per share